These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15599498)

  • 1. Sample preparation for pharmaceutical analysis.
    Fu X; Liao Y; Liu H
    Anal Bioanal Chem; 2005 Jan; 381(1):75-7. PubMed ID: 15599498
    [No Abstract]   [Full Text] [Related]  

  • 2. Some considerations regarding drug determinations in biological fluids with physico-chemical methodologies [proceedings].
    De Graeve J
    Ann Biol Clin (Paris); 1978; 36(3):161-8. PubMed ID: 360889
    [No Abstract]   [Full Text] [Related]  

  • 3. Sample preparation for the HPLC analysis of drugs in biological fluids.
    McDowall RD; Doyle E; Murkitt GS; Picot VS
    J Pharm Biomed Anal; 1989; 7(9):1087-96. PubMed ID: 2490115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of pharmaceuticals in biological fluids using high-performance liquid chromatography coupled to mass spectrometry: a review.
    Plumb RS; Dear GJ; Mallett DN; Higton DM; Pleasance S; Biddlecombe RA
    Xenobiotica; 2001; 31(8-9):599-617. PubMed ID: 11569528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioanalysis of drugs by liquid-phase microextraction coupled to separation techniques.
    Pedersen-Bjergaard S; Rasmussen KE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(1):3-12. PubMed ID: 15680784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography-mass spectrometry (LC-MS)-based lipidomics for studies of body fluids and tissues.
    Nygren H; Seppänen-Laakso T; Castillo S; Hyötyläinen T; Orešič M
    Methods Mol Biol; 2011; 708():247-57. PubMed ID: 21207295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of pharmaceutical impurities in formulated dosage forms.
    Pan C; Liu F; Motto M
    J Pharm Sci; 2011 Apr; 100(4):1228-59. PubMed ID: 24081463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sampling and analysis of metabolomes in biological fluids.
    Nunes de Paiva MJ; Menezes HC; de Lourdes Cardeal Z
    Analyst; 2014 Aug; 139(15):3683-94. PubMed ID: 24941103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microextraction by packed sorbent (MEPS): a tutorial.
    Abdel-Rehim M
    Anal Chim Acta; 2011 Sep; 701(2):119-28. PubMed ID: 21801877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical methods used in conjunction with solid-phase microextraction: a review of recent bioanalytical applications.
    Musteata ML; Musteata FM
    Bioanalysis; 2009 Sep; 1(6):1081-102. PubMed ID: 21083077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical and biomedical analysis of cannabinoids: A critical review.
    Citti C; Braghiroli D; Vandelli MA; Cannazza G
    J Pharm Biomed Anal; 2018 Jan; 147():565-579. PubMed ID: 28641906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finding key impurities in different manufacturing routes of a drug substance using liquid chromatography/mass spectrometry followed by principal components analysis.
    Carrier D; Eckers C; Arnoult T; Thurston T; Major H
    Rapid Commun Mass Spectrom; 2007; 21(23):3946-8. PubMed ID: 17975854
    [No Abstract]   [Full Text] [Related]  

  • 14. Multidimensional separations in the pharmaceutical arena.
    Guttman A; Varoglu M; Khandurina J
    Drug Discov Today; 2004 Feb; 9(3):136-44. PubMed ID: 14960391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical derivatization in bioanalysis.
    Perez HL; Evans CA
    Bioanalysis; 2015 Oct; 7(19):2435-7. PubMed ID: 26526650
    [No Abstract]   [Full Text] [Related]  

  • 16. [High resolution gas chromatography and its application in pharmaceutical analysis].
    Fang HJ
    Yao Xue Xue Bao; 1990; 25(11):869-80. PubMed ID: 2099097
    [No Abstract]   [Full Text] [Related]  

  • 17. Direct analysis in real time--high resolution mass spectrometry as a valuable tool for the pharmaceutical drug development.
    Srbek J; Klejdus B; Douša M; Břicháč J; Stasiak P; Reitmajer J; Nováková L
    Talanta; 2014 Dec; 130():518-26. PubMed ID: 25159441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry in clinical chemistry.
    Roboz J
    Adv Clin Chem; 1975; 17():109-91. PubMed ID: 1093361
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sample preparation and bioanalysis in mass spectrometry].
    Bourgogne E; Wagner M
    Ann Biol Clin (Paris); 2015; 73(1):11-23. PubMed ID: 25582719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated optimization of mass spectrometric parameters in 'Tune' mode for impure analytes in dirty samples using gradient high-performance liquid chromatography.
    Rogatsky E; Stein D
    Rapid Commun Mass Spectrom; 2005; 19(24):3759-60. PubMed ID: 16308844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.